Semaglutide 2.4 mg reduces the need for blood pressure and cholesterol medications in pooled STEP trial analysis | Research

The takeaway

Pooled STEP trial analysis shows semaglutide 2.4 mg enabled more patients to reduce or stop antihypertensive and lipid-lowering medications versus placebo, while fewer needed treatment intensification.

Fewer pills needed
Semaglutide 2.4 mg enabled more patients to reduce or stop blood pressure and cholesterol medications—a practical benefit reducing polypharmacy burden

What the researchers found

Semaglutide 2.4 mg vs placebo: more treatment intensity reduction + more treatment discontinuation for both antihypertensives and lipid-lowering drugs. Less treatment intensification. Greater weight loss correlated with medication changes. Two pooled populations: with and without T2DM.

Why it matters

Polypharmacy is a major problem in cardiometabolic disease. Demonstrating that semaglutide reduces medication burden—not just weight and metabolic parameters—has practical implications for patients taking multiple pills daily.

How the study worked

Post hoc analysis of pooled STEP 1, 3, 6, 8 (overweight/obesity) and STEP 2, 6 (overweight/obesity + T2DM). Antihypertensive and lipid-lowering medication changes from randomization to end of treatment.

What this study cannot tell us

Post hoc analysis. Treatment changes were clinician-driven (not standardized). Cannot determine if medication changes were appropriate or sufficient. Pooled heterogeneous trial populations.

How to read the evidence

Post hoc analysis of 5 major RCTs. Consistent findings across populations.

When this study was published

Published in 2025.

The bigger picture

Reducing the number of daily medications improves quality of life, adherence, and potentially reduces healthcare costs. Semaglutide's ability to "de-prescribe" existing medications is a clinically meaningful benefit.

Questions still open

How many blood pressure pills can semaglutide replace on average?
Should clinicians proactively plan medication reduction with semaglutide initiation?
Does medication reduction contribute to adherence benefits?

Common questions

Can semaglutide reduce the number of pills I take?

Yes. This analysis of 5 clinical trials found patients on semaglutide were more likely to reduce or stop their blood pressure and cholesterol medications. The weight loss from semaglutide improved these conditions enough that fewer medications were needed.

Should my doctor adjust my other medications after starting semaglutide?

Yes—and this data supports proactive medication review. As you lose weight on semaglutide, blood pressure and cholesterol often improve enough to reduce or stop other medications. Your doctor should monitor these values and adjust your medications accordingly.

Read the original research

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.

Obesity (Silver Spring, Md.), 33(2), 267-277

View on PubMed ↗Publisher’s paper ↗

Citation

Tchang, Beverly G; Knight, Michael G; Adelborg, Kasper; Clements, Jennifer N; Iversen, Aske Thorn; Traina, Andrea. (2025). Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.. Obesity (Silver Spring, Md.), 33(2), 267-277. https://doi.org/10.1002/oby.24202